Back
AnGes 10K Form
Buy
57
AMGXF
AnGes
Last Price:
$0.36
Seasonality Move:
-7.69%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AMGXF News And Ratings
See the #1 stock for the next 7 days that we like better than AMGXF
AMGXF Financial Statistics
Sales & Book Value
| Annual Sales: | $4.3M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.07 |
| Price / Book: | 5.48 |
Profitability
| EPS (TTM): | -0.22770 |
|---|---|
| Net Income (TTM): | $-49.1M |
| Gross Margin: | $1.6M |
| Return on Equity: | -33.92% |
| Return on Assets: | -29.46% |
AnGes Earnings Forecast
Key AnGes Financial Ratios
-
The Gross Profit Margin over the past 17 years for AMGXF is 38.48%.
-
The Selling, General & Administrative Expenses for AMGXF have been equal to 865.98% of Gross Profit Margin.
-
The Research & Development expenses have been 587.81% of Revenue.
-
The Net Earning history of AMGXF is -4,370.31% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 9 years.
AnGes Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AMGXF |
| Website: | anges.co.jp |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.99 |
| Quick Ratio: | 1.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |